Bausch Health Companies Inc. Gain (Loss) on Disposition of Assets
Bausch Health Companies Inc. (BHC) reported Gain (Loss) on Disposition of Assets of $3.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-07-30
- Bausch Health Companies Inc. gain (loss) on disposition of assets for the quarter ending 2026-06-30 was $0.00.
- Bausch Health Companies Inc. gain (loss) on disposition of assets for the quarter ending 2026-03-31 was $3.00M.
- Bausch Health Companies Inc. gain (loss) on disposition of assets for the quarter ending 2025-12-31 was $0.00.
- Bausch Health Companies Inc. gain (loss) on disposition of assets for the quarter ending 2025-09-30 was $6.00M, a 20.00% increase year-over-year.
- Bausch Health Companies Inc. gain (loss) on disposition of assets for fiscal 2025 was $6.00M, a 40.00% decline from fiscal 2024.
- Bausch Health Companies Inc. gain (loss) on disposition of assets for fiscal 2024 was $10.00M, a 233.33% increase from fiscal 2023.
- Bausch Health Companies Inc. gain (loss) on disposition of assets for fiscal 2023 was $3.00M, a 40.00% decline from fiscal 2022.
- Bausch Health Companies Inc. gain (loss) on disposition of assets for fiscal 2022 was $5.00M, a 150.00% increase from fiscal 2021.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $3.00M 10-Q · filed 2026-07-30 | $3.00M derived: sum of 3 quarters · filed 2026-07-30 | $9.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $3.00M 10-Q · filed 2026-04-30 | $3.00M derived: sum of 2 quarters · filed 2026-04-30 | $9.00M derived: sum of 3 quarters · filed 2026-04-30 | $9.00M derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $6.00M derived: sum of 2 quarters · filed 2026-02-19 | $6.00M derived: sum of 3 quarters · filed 2026-02-19 | $6.00M 10-K · filed 2026-02-19 |
| 2025-09-30 | $6.00M 10-Q · filed 2025-10-30 | $6.00M derived: sum of 2 quarters · filed 2025-10-30 | $6.00M 10-Q · filed 2025-10-30 | $6.00M derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-06-30 | $0.00 10-Q · filed 2025-07-31 | $0.00 10-Q · filed 2026-07-30 | $0.00 derived: sum of 3 quarters · filed 2026-04-30 | $5.00M derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-03-31 | $0.00 10-Q · filed 2026-04-30 | $0.00 derived: sum of 2 quarters · filed 2026-04-30 | $5.00M derived: sum of 3 quarters · filed 2026-04-30 | $6.00M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $5.00M derived: sum of 2 quarters · filed 2026-02-19 | $6.00M derived: sum of 3 quarters · filed 2026-02-19 | $10.00M 10-K · filed 2026-02-19 |
| 2024-09-30 | $5.00M 10-Q · filed 2025-10-30 | $6.00M derived: sum of 2 quarters · filed 2025-10-30 | $10.00M 10-Q · filed 2025-10-30 | $9.00M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $1.00M 10-Q · filed 2025-07-31 | $5.00M 10-Q · filed 2025-07-31 | $4.00M derived: sum of 3 quarters · filed 2026-02-19 | $9.00M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $4.00M 10-Q · filed 2025-05-01 | $3.00M derived: sum of 2 quarters · filed 2026-02-19 | $8.00M derived: sum of 3 quarters · filed 2026-02-19 | $7.00M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $4.00M derived: sum of 2 quarters · filed 2026-02-19 | $3.00M derived: sum of 3 quarters · filed 2026-02-19 | $3.00M 10-K · filed 2026-02-19 |
| 2023-09-30 | $5.00M 10-Q · filed 2024-10-31 | $4.00M derived: sum of 2 quarters · filed 2024-10-31 | $4.00M 10-Q · filed 2024-10-31 | $6.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | -$1.00M 10-Q · filed 2024-08-01 | -$1.00M 10-Q · filed 2024-08-01 | $1.00M derived: sum of 3 quarters · filed 2025-02-20 | $1.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | $2.00M derived: sum of 2 quarters · filed 2025-02-20 | $2.00M derived: sum of 3 quarters · filed 2025-02-20 | $5.00M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $2.00M derived: sum of 2 quarters · filed 2025-02-20 | $5.00M derived: sum of 3 quarters · filed 2025-02-20 | $5.00M 10-K · filed 2025-02-20 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-02 | $3.00M derived: sum of 2 quarters · filed 2023-11-02 | $3.00M 10-Q · filed 2023-11-02 | $3.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $3.00M 10-Q · filed 2023-08-03 | $3.00M 10-Q · filed 2023-08-03 | $3.00M derived: sum of 3 quarters · filed 2024-02-22 | -$18.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | -$21.00M derived: sum of 3 quarters · filed 2024-02-22 | -$21.00M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$21.00M derived: sum of 2 quarters · filed 2024-02-22 | -$21.00M derived: sum of 3 quarters · filed 2024-02-22 | $2.00M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$21.00M 10-Q · filed 2022-11-03 | -$21.00M derived: sum of 2 quarters · filed 2022-11-03 | $2.00M 10-Q · filed 2022-11-03 | $2.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | $23.00M 10-Q · filed 2022-08-09 | $23.00M derived: sum of 3 quarters · filed 2023-02-23 | $23.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $23.00M 10-Q · filed 2022-05-10 | $23.00M derived: sum of 2 quarters · filed 2023-02-23 | $23.00M derived: sum of 3 quarters · filed 2023-02-23 | $23.00M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $1.00M 10-K · filed 2023-02-23 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $1.00M 10-Q · filed 2021-11-02 | $22.00M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-03 | $1.00M 10-Q · filed 2021-08-03 | $22.00M derived: sum of 3 quarters · filed 2022-05-11 | $23.00M derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-03-31 | $1.00M 10-Q · filed 2021-05-04 | $22.00M derived: sum of 2 quarters · filed 2022-05-11 | $23.00M derived: sum of 3 quarters · filed 2022-05-11 | $22.00M derived: sum of 4 quarters · filed 2022-05-11 |
| 2019-12-31 | $21.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $22.00M derived: sum of 2 quarters · filed 2022-05-11 | $21.00M derived: sum of 3 quarters · filed 2022-05-11 | $31.00M 8-K · filed 2022-05-11 |
| 2019-09-30 | $1.00M 10-Q · filed 2020-11-03 | $0.00 derived: sum of 2 quarters · filed 2020-11-03 | $10.00M 10-Q · filed 2020-11-03 | $30.00M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-06-30 | -$1.00M 10-Q · filed 2020-08-06 | $9.00M 10-Q · filed 2020-08-06 | $29.00M derived: sum of 3 quarters · filed 2021-05-04 | $3.00M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-03-31 | $10.00M 10-Q · filed 2020-05-07 | $30.00M derived: sum of 2 quarters · filed 2021-05-04 | $4.00M derived: sum of 3 quarters · filed 2021-05-04 | $4.00M derived: sum of 4 quarters · filed 2021-05-04 |
| 2018-12-31 | $20.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | -$6.00M derived: sum of 2 quarters · filed 2021-05-04 | -$6.00M derived: sum of 3 quarters · filed 2021-05-04 | -$6.00M 8-K · filed 2021-05-04 |
| 2018-09-30 | -$26.00M 10-Q · filed 2019-11-04 | -$26.00M derived: sum of 2 quarters · filed 2019-11-04 | -$26.00M 10-Q · filed 2019-11-04 | -$38.00M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | -$12.00M derived: sum of 3 quarters · filed 2020-02-19 | -$12.00M derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-06 | -$12.00M derived: sum of 2 quarters · filed 2020-02-19 | -$12.00M derived: sum of 3 quarters · filed 2020-02-19 | -$35.00M derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | -$12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | -$12.00M derived: sum of 2 quarters · filed 2020-02-19 | -$35.00M derived: sum of 3 quarters · filed 2020-02-19 | -$37.00M 10-K · filed 2020-02-19 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-06 | -$23.00M derived: sum of 2 quarters · filed 2018-11-06 | -$25.00M 10-Q · filed 2018-11-06 | -$28.00M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-06-30 | -$23.00M 10-Q · filed 2018-08-07 | -$25.00M 10-Q · filed 2018-08-07 | -$28.00M derived: sum of 3 quarters · filed 2019-02-20 | -$28.00M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-03-31 | -$2.00M 10-Q · filed 2018-05-08 | -$5.00M derived: sum of 2 quarters · filed 2019-02-20 | -$5.00M derived: sum of 3 quarters · filed 2019-02-20 | $6.00M derived: sum of 4 quarters · filed 2019-02-20 |
| 2016-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$3.00M derived: sum of 2 quarters · filed 2019-02-20 | $8.00M derived: sum of 3 quarters · filed 2019-02-20 | $6.00M 10-K · filed 2019-02-20 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-07 | $11.00M derived: sum of 2 quarters · filed 2017-11-07 | $9.00M 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $11.00M 10-Q · filed 2017-08-08 | $9.00M 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | -$2.00M 10-Q · filed 2017-05-09 | |||
| 2015-12-31 | -$8.00M 8-K · filed 2018-08-10 | |||
| 2014-12-31 | $251.00M 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |